Chemistry:DALT

From HandWiki
Short description: Chemical compound
DALT
DALT-structure.png
Clinical data
Routes of
administration
Oral, insufflated, rectal, smoked, IM, IV[citation needed]
ATC code
  • none
Legal status
Legal status
  • DE: NpSG (Industrial and scientific use only)
  • UK: Class A
  • US: Analogue to a Schedule I/II drug (possibly)
  • May be covered under similar Analogue bills in other countries
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC16H20N2
Molar mass240.350 g·mol−1
3D model (JSmol)
  (verify)

N,N-Diallyltryptamine (DALT) is a tryptamine derivative which has been identified as a new psychoactive substance.[1][2] It has been used as an intermediate in the preparation of radiolabeled diethyltryptamine.[3]

One of the more pronounced effects of this substance is a sharp increase in body temperature, similar to the effects of 2,4-Dinitrophenol (DNP). Unlike DNP, DALT is suggested to be safer, as it belongs to the tryptamine family. DALT exhibits weak psychoactive properties, particularly among tryptamines. The metabolic effects of this substance on body temperature, and its non-toxic nature, leads to the viability of this substance being used for emergency situations in cold weather environments, or as a weight loss supplement.[citation needed]

See also

References

  1. "Metabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC-MS, LC-MSn, and LC-HR-MS-MS". Analytical and Bioanalytical Chemistry 407 (25): 7831–42. October 2015. doi:10.1007/s00216-015-8955-0. PMID 26297461. http://researchonline.ljmu.ac.uk/id/eprint/3406/1/ABC-01148-2015.R1.pdf. 
  2. "n, and LC-HR-MS/MS". Analytical and Bioanalytical Chemistry 409 (6): 1681–1695. February 2017. doi:10.1007/s00216-016-0117-5. PMID 27933361. http://researchonline.ljmu.ac.uk/id/eprint/4885/1/ABC_5F_7Me_5%2C6MD-DALT_accepted.pdf. 
  3. "Microwave-accelerated synthesis of psychoactive deuterated N,N-dialkylated-[α,α,β,β-d4]-tryptamines". Journal of Labelled Compounds and Radiopharmaceuticals 51 (14): 423–429. 2008. doi:10.1002/jlcr.1557.